Citation: T. Wurch et al., Induction of a high-affinity ketanserin binding site at the 5-hydroxytryptamine(1B) receptor by modification of its carboxy-terminal intracellular portion, BIOCH PHARM, 59(9), 2000, pp. 1117-1121
Authors:
John, GW
Pauwels, PJ
Perez, M
Halazy, S
Le Grand, B
Verscheure, Y
Valentin, JP
Palmier, C
Wurch, T
Chopin, P
Marien, M
Kleven, MS
Koek, W
Assie, MB
Carilla-Durand, E
Tarayre, JP
Colpaert, FC
Citation: Gw. John et al., F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine, J PHARM EXP, 290(1), 1999, pp. 83-95
Authors:
Perez, M
Pauwels, PJ
Pallard-Sigogneau, I
Fourrier, C
Chopin, P
Palmier, C
Colovray, V
Halazy, S
Citation: M. Perez et al., Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors, BIOORG MED, 8(23), 1998, pp. 3423-3428